aluates Reports

$ 0.0

Automative

Global Molecular Diagnostics Cancer Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34N2713

Global Molecular Diagnostics Cancer Market Insights Forecast to 2028

BUY CHAPTERS

Global Molecular Diagnostics Cancer Market Insights, Forecast to 2030

Code: QYRE-Auto-34N2713

Report

December 2024

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Danaher

Siemens AG

Abbott Laboratories

ICON

Astrazeneca plc

MDxHealth

Invitae

PlexBio

Thermo Fisher Scientific

Guardant Health

Biocartis

Bio-Techne

Merck

Foundation Medicine

10X Genomics

Biodesix

CytoTrack

GenomOncology

Luminex

Molecular Diagnostics Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Molecular Diagnostics Cancer Market

A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.

Market Analysis and Insights: Global Molecular Diagnostics Cancer Market

The global Molecular Diagnostics Cancer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Molecular Diagnostics Cancer market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Molecular Diagnostics Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Diagnostics Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Diagnostics Cancer revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Molecular Diagnostics Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Molecular Diagnostics Cancer revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Molecular Diagnostics Cancer Market Report

Report Metric	Details
Report Name	Molecular Diagnostics Cancer Market
CAGR	5%
Segment by Type	Pharmacogenomic Diagnosis Liquid Biopsy Other
Segment by Application	Respiratory Cancer Cancer of Digestive System Cancer of Urinary System Cancer of Circulatory System Motor System Cancer Reproductive System Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Diagnostics Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnostics Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Molecular Diagnostics Cancer Market report?

Ans: The main players in the Molecular Diagnostics Cancer Market are Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex

What are the Application segmentation covered in the Molecular Diagnostics Cancer Market report?

Ans: The Applications covered in the Molecular Diagnostics Cancer Market report are Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other

What are the Type segmentation covered in the Molecular Diagnostics Cancer Market report?

Ans: The Types covered in the Molecular Diagnostics Cancer Market report are Pharmacogenomic Diagnosis, Liquid Biopsy, Other

Recommended Reports

Molecular Cancer Diagnostics

Cancer Diagnosis Testing

Molecular Diagnostic Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Pharmacogenomic Diagnosis

1.2.3 Liquid Biopsy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Respiratory Cancer

1.3.3 Cancer of Digestive System

1.3.4 Cancer of Urinary System

1.3.5 Cancer of Circulatory System

1.3.6 Motor System Cancer

1.3.7 Reproductive System Cancer

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnostics Cancer Market Perspective (2019-2030)

2.2 Global Molecular Diagnostics Cancer Growth Trends by Region

2.2.1 Molecular Diagnostics Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2019-2024)

2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2025-2030)

2.3 Molecular Diagnostics Cancer Market Dynamics

2.3.1 Molecular Diagnostics Cancer Industry Trends

2.3.2 Molecular Diagnostics Cancer Market Drivers

2.3.3 Molecular Diagnostics Cancer Market Challenges

2.3.4 Molecular Diagnostics Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Molecular Diagnostics Cancer by Players

3.1.1 Global Molecular Diagnostics Cancer Revenue by Players (2019-2024)

3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Molecular Diagnostics Cancer, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio

3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2023

3.5 Global Key Players of Molecular Diagnostics Cancer Head office and Area Served

3.6 Global Key Players of Molecular Diagnostics Cancer, Product and Application

3.7 Global Key Players of Molecular Diagnostics Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics Cancer Breakdown Data by Type

4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2019-2024)

4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2025-2030)

5 Molecular Diagnostics Cancer Breakdown Data by Application

5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2019-2024)

5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Molecular Diagnostics Cancer Market Size (2019-2030)

6.2 North America Molecular Diagnostics Cancer Market Size by Type

6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2019-2024)

6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2025-2030)

6.2.3 North America Molecular Diagnostics Cancer Market Share by Type (2019-2030)

6.3 North America Molecular Diagnostics Cancer Market Size by Application

6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2019-2024)

6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2025-2030)

6.3.3 North America Molecular Diagnostics Cancer Market Share by Application (2019-2030)

6.4 North America Molecular Diagnostics Cancer Market Size by Country

6.4.1 North America Molecular Diagnostics Cancer Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2019-2024)

6.4.3 North America Molecular Diagnostics Cancer Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Molecular Diagnostics Cancer Market Size (2019-2030)

7.2 Europe Molecular Diagnostics Cancer Market Size by Type

7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2019-2024)

7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2025-2030)

7.2.3 Europe Molecular Diagnostics Cancer Market Share by Type (2019-2030)

7.3 Europe Molecular Diagnostics Cancer Market Size by Application

7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2019-2024)

7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2025-2030)

7.3.3 Europe Molecular Diagnostics Cancer Market Share by Application (2019-2030)

7.4 Europe Molecular Diagnostics Cancer Market Size by Country

7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2019-2024)

7.4.3 Europe Molecular Diagnostics Cancer Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Molecular Diagnostics Cancer Market Size (2019-2030)

8.2 China Molecular Diagnostics Cancer Market Size by Type

8.2.1 China Molecular Diagnostics Cancer Market Size by Type (2019-2024)

8.2.2 China Molecular Diagnostics Cancer Market Size by Type (2025-2030)

8.2.3 China Molecular Diagnostics Cancer Market Share by Type (2019-2030)

8.3 China Molecular Diagnostics Cancer Market Size by Application

8.3.1 China Molecular Diagnostics Cancer Market Size by Application (2019-2024)

8.3.2 China Molecular Diagnostics Cancer Market Size by Application (2025-2030)

8.3.3 China Molecular Diagnostics Cancer Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Molecular Diagnostics Cancer Market Size (2019-2030)

9.2 Asia Molecular Diagnostics Cancer Market Size by Type

9.2.1 Asia Molecular Diagnostics Cancer Market Size by Type (2019-2024)

9.2.2 Asia Molecular Diagnostics Cancer Market Size by Type (2025-2030)

9.2.3 Asia Molecular Diagnostics Cancer Market Share by Type (2019-2030)

9.3 Asia Molecular Diagnostics Cancer Market Size by Application

9.3.1 Asia Molecular Diagnostics Cancer Market Size by Application (2019-2024)

9.3.2 Asia Molecular Diagnostics Cancer Market Size by Application (2025-2030)

9.3.3 Asia Molecular Diagnostics Cancer Market Share by Application (2019-2030)

9.4 Asia Molecular Diagnostics Cancer Market Size by Region

9.4.1 Asia Molecular Diagnostics Cancer Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Molecular Diagnostics Cancer Market Size by Region (2019-2024)

9.4.3 Asia Molecular Diagnostics Cancer Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Type

10.2.1 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Application

10.3.1 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country

10.4.1 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Molecular Diagnostics Cancer Introduction

11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Danaher

11.2.1 Danaher Company Details

11.2.2 Danaher Business Overview

11.2.3 Danaher Molecular Diagnostics Cancer Introduction

11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.2.5 Danaher Recent Developments

11.3 Siemens

11.3.1 Siemens Company Details

11.3.2 Siemens Business Overview

11.3.3 Siemens Molecular Diagnostics Cancer Introduction

11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.3.5 Siemens Recent Developments

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Details

11.4.2 Abbott Laboratories Business Overview

11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction

11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.4.5 Abbott Laboratories Recent Developments

11.5 ICON Plc

11.5.1 ICON Plc Company Details

11.5.2 ICON Plc Business Overview

11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction

11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.5.5 ICON Plc Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction

11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.6.5 AstraZeneca Recent Developments

11.7 MDxHealth

11.7.1 MDxHealth Company Details

11.7.2 MDxHealth Business Overview

11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction

11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.7.5 MDxHealth Recent Developments

11.8 Invitae

11.8.1 Invitae Company Details

11.8.2 Invitae Business Overview

11.8.3 Invitae Molecular Diagnostics Cancer Introduction

11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.8.5 Invitae Recent Developments

11.9 PlexBio

11.9.1 PlexBio Company Details

11.9.2 PlexBio Business Overview

11.9.3 PlexBio Molecular Diagnostics Cancer Introduction

11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.9.5 PlexBio Recent Developments

11.10 Thermo Fisher Scientific

11.10.1 Thermo Fisher Scientific Company Details

11.10.2 Thermo Fisher Scientific Business Overview

11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction

11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.10.5 Thermo Fisher Scientific Recent Developments

11.11 Guardant Health

11.11.1 Guardant Health Company Details

11.11.2 Guardant Health Business Overview

11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction

11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.11.5 Guardant Health Recent Developments

11.12 Biocartis

11.12.1 Biocartis Company Details

11.12.2 Biocartis Business Overview

11.12.3 Biocartis Molecular Diagnostics Cancer Introduction

11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.12.5 Biocartis Recent Developments

11.13 Bio-Techne

11.13.1 Bio-Techne Company Details

11.13.2 Bio-Techne Business Overview

11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction

11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.13.5 Bio-Techne Recent Developments

11.14 Merck

11.14.1 Merck Company Details

11.14.2 Merck Business Overview

11.14.3 Merck Molecular Diagnostics Cancer Introduction

11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.14.5 Merck Recent Developments

11.15 Foundation Medicine

11.15.1 Foundation Medicine Company Details

11.15.2 Foundation Medicine Business Overview

11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction

11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.15.5 Foundation Medicine Recent Developments

11.16 10X Genomics

11.16.1 10X Genomics Company Details

11.16.2 10X Genomics Business Overview

11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction

11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.16.5 10X Genomics Recent Developments

11.17 Biodesix

11.17.1 Biodesix Company Details

11.17.2 Biodesix Business Overview

11.17.3 Biodesix Molecular Diagnostics Cancer Introduction

11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.17.5 Biodesix Recent Developments

11.18 CytoTrack

11.18.1 CytoTrack Company Details

11.18.2 CytoTrack Business Overview

11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction

11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.18.5 CytoTrack Recent Developments

11.19 GenomOncology

11.19.1 GenomOncology Company Details

11.19.2 GenomOncology Business Overview

11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction

11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.19.5 GenomOncology Recent Developments

11.20 Luminex

11.20.1 Luminex Company Details

11.20.2 Luminex Business Overview

11.20.3 Luminex Molecular Diagnostics Cancer Introduction

11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.20.5 Luminex Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Danaher

Siemens AG

Abbott Laboratories

ICON

Astrazeneca plc

MDxHealth

Invitae

PlexBio

Thermo Fisher Scientific

Guardant Health

Biocartis

Bio-Techne

Merck

Foundation Medicine

10X Genomics

Biodesix

CytoTrack

GenomOncology

Luminex

List of Tables

Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Pharmacogenomic Diagnosis

Table 3. Key Players of Liquid Biopsy

Table 4. Key Players of Other

Table 5. Global Molecular Diagnostics Cancer Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Molecular Diagnostics Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Molecular Diagnostics Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Molecular Diagnostics Cancer Market Share by Region (2019-2024)

Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Molecular Diagnostics Cancer Market Share by Region (2025-2030)

Table 11. Molecular Diagnostics Cancer Market Trends

Table 12. Molecular Diagnostics Cancer Market Drivers

Table 13. Molecular Diagnostics Cancer Market Challenges

Table 14. Molecular Diagnostics Cancer Market Restraints

Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Molecular Diagnostics Cancer Revenue Share by Players (2019-2024)

Table 17. Global Top Molecular Diagnostics Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2023)

Table 18. Global Molecular Diagnostics Cancer Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Molecular Diagnostics Cancer, Headquarters and Area Served

Table 21. Global Key Players of Molecular Diagnostics Cancer, Product and Application

Table 22. Global Key Players of Molecular Diagnostics Cancer, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2019-2024)

Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2025-2030)

Table 28. Global Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Molecular Diagnostics Cancer Revenue Share by Application (2019-2024)

Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Molecular Diagnostics Cancer Revenue Share by Application (2025-2030)

Table 32. North America Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Molecular Diagnostics Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Molecular Diagnostics Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Molecular Diagnostics Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Molecular Diagnostics Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Molecular Diagnostics Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Molecular Diagnostics Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Molecular Diagnostics Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Molecular Diagnostics Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Molecular Diagnostics Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Molecular Diagnostics Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Molecular Diagnostics Cancer Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Molecular Diagnostics Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Molecular Diagnostics Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Molecular Diagnostics Cancer Product

Table 67. Roche Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 68. Roche Recent Developments

Table 69. Danaher Company Details

Table 70. Danaher Business Overview

Table 71. Danaher Molecular Diagnostics Cancer Product

Table 72. Danaher Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 73. Danaher Recent Developments

Table 74. Siemens Company Details

Table 75. Siemens Business Overview

Table 76. Siemens Molecular Diagnostics Cancer Product

Table 77. Siemens Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 78. Siemens Recent Developments

Table 79. Abbott Laboratories Company Details

Table 80. Abbott Laboratories Business Overview

Table 81. Abbott Laboratories Molecular Diagnostics Cancer Product

Table 82. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 83. Abbott Laboratories Recent Developments

Table 84. ICON Plc Company Details

Table 85. ICON Plc Business Overview

Table 86. ICON Plc Molecular Diagnostics Cancer Product

Table 87. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 88. ICON Plc Recent Developments

Table 89. AstraZeneca Company Details

Table 90. AstraZeneca Business Overview

Table 91. AstraZeneca Molecular Diagnostics Cancer Product

Table 92. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 93. AstraZeneca Recent Developments

Table 94. MDxHealth Company Details

Table 95. MDxHealth Business Overview

Table 96. MDxHealth Molecular Diagnostics Cancer Product

Table 97. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 98. MDxHealth Recent Developments

Table 99. Invitae Company Details

Table 100. Invitae Business Overview

Table 101. Invitae Molecular Diagnostics Cancer Product

Table 102. Invitae Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 103. Invitae Recent Developments

Table 104. PlexBio Company Details

Table 105. PlexBio Business Overview

Table 106. PlexBio Molecular Diagnostics Cancer Product

Table 107. PlexBio Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 108. PlexBio Recent Developments

Table 109. Thermo Fisher Scientific Company Details

Table 110. Thermo Fisher Scientific Business Overview

Table 111. Thermo Fisher Scientific Molecular Diagnostics Cancer Product

Table 112. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 113. Thermo Fisher Scientific Recent Developments

Table 114. Guardant Health Company Details

Table 115. Guardant Health Business Overview

Table 116. Guardant Health Molecular Diagnostics Cancer Product

Table 117. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 118. Guardant Health Recent Developments

Table 119. Biocartis Company Details

Table 120. Biocartis Business Overview

Table 121. Biocartis Molecular Diagnostics Cancer Product

Table 122. Biocartis Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 123. Biocartis Recent Developments

Table 124. Bio-Techne Company Details

Table 125. Bio-Techne Business Overview

Table 126. Bio-Techne Molecular Diagnostics Cancer Product

Table 127. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 128. Bio-Techne Recent Developments

Table 129. Merck Company Details

Table 130. Merck Business Overview

Table 131. Merck Molecular Diagnostics Cancer Product

Table 132. Merck Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 133. Merck Recent Developments

Table 134. Foundation Medicine Company Details

Table 135. Foundation Medicine Business Overview

Table 136. Foundation Medicine Molecular Diagnostics Cancer Product

Table 137. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 138. Foundation Medicine Recent Developments

Table 139. 10X Genomics Company Details

Table 140. 10X Genomics Business Overview

Table 141. 10X Genomics Molecular Diagnostics Cancer Product

Table 142. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 143. 10X Genomics Recent Developments

Table 144. Biodesix Company Details

Table 145. Biodesix Business Overview

Table 146. Biodesix Molecular Diagnostics Cancer Product

Table 147. Biodesix Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 148. Biodesix Recent Developments

Table 149. CytoTrack Company Details

Table 150. CytoTrack Business Overview

Table 151. CytoTrack Molecular Diagnostics Cancer Product

Table 152. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 153. CytoTrack Recent Developments

Table 154. GenomOncology Company Details

Table 155. GenomOncology Business Overview

Table 156. GenomOncology Molecular Diagnostics Cancer Product

Table 157. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 158. GenomOncology Recent Developments

Table 159. Luminex Company Details

Table 160. Luminex Business Overview

Table 161. Luminex Molecular Diagnostics Cancer Product

Table 162. Luminex Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 163. Luminex Recent Developments

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Molecular Diagnostics Cancer Market Share by Type: 2023 VS 2030

Figure 3. Pharmacogenomic Diagnosis Features

Figure 4. Liquid Biopsy Features

Figure 5. Other Features

Figure 6. Global Molecular Diagnostics Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Molecular Diagnostics Cancer Market Share by Application: 2023 VS 2030

Figure 8. Respiratory Cancer Case Studies

Figure 9. Cancer of Digestive System Case Studies

Figure 10. Cancer of Urinary System Case Studies

Figure 11. Cancer of Circulatory System Case Studies

Figure 12. Motor System Cancer Case Studies

Figure 13. Reproductive System Cancer Case Studies

Figure 14. Other Case Studies

Figure 15. Molecular Diagnostics Cancer Report Years Considered

Figure 16. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Molecular Diagnostics Cancer Market Share by Region: 2023 VS 2030

Figure 19. Global Molecular Diagnostics Cancer Market Share by Players in 2023

Figure 20. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2023

Figure 22. North America Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Molecular Diagnostics Cancer Market Share by Type (2019-2030)

Figure 24. North America Molecular Diagnostics Cancer Market Share by Application (2019-2030)

Figure 25. North America Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 26. United States Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Molecular Diagnostics Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Molecular Diagnostics Cancer Market Share by Type (2019-2030)

Figure 30. Europe Molecular Diagnostics Cancer Market Share by Application (2019-2030)

Figure 31. Europe Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 32. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Molecular Diagnostics Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Molecular Diagnostics Cancer Market Share by Type (2019-2030)

Figure 40. China Molecular Diagnostics Cancer Market Share by Application (2019-2030)

Figure 41. Asia Molecular Diagnostics Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Molecular Diagnostics Cancer Market Share by Type (2019-2030)

Figure 43. Asia Molecular Diagnostics Cancer Market Share by Application (2019-2030)

Figure 44. Asia Molecular Diagnostics Cancer Market Share by Region (2019-2030)

Figure 45. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 55. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 62. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 63. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 64. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 65. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 66. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 67. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 68. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 69. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 71. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 72. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 73. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 74. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 75. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 76. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 77. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 78. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 79. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 80. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Molecular Diagnostics Market Research Report 2024

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Cancer Molecular Biomarkers Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Point of care Molecular Diagnostic Solution Market Research Report 2025

Veterinary Molecular Diagnostics Market

Molecular Diagnostic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis and Therapy Market Insights Forecast to 2030

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Gallbladder Cancer Market Research Report 2024

Global Chest Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Microbiology Market Insights Forecast to 2030

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Lymphoma Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions